Nondepleting Anti-Cd4 Has an Immediate Action on Diabetogenic Effector Cells, Halting Their Destruction of Pancreatic Cells

Journal of Immunology - United States
doi 10.4049/jimmunol.165.4.1949
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

IL-1α, IL-1β, and IFN-γ Mark Β Cells for Fas-Dependent Destruction by Diabetogenic CD4+ T Lymphocytes

Journal of Clinical Investigation
Medicine
2000English

Origins of CD4+ Effector and Central Memory T Cells

Nature Immunology
AllergyImmunology
2011English

Antigen-Specific CD4 Cells Assist CD8 T-Effector Cells in Eliminating Keratinocytes

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2010English

Protective Effector Memory CD4 T Cells Depend on ICOS for Survival

PLoS ONE
Multidisciplinary
2011English

IFN-γ Receptor Deficiency Prevents Diabetes Induction by Diabetogenic CD4+T Cells but Not CD8+T Cells

European Journal of Immunology
AllergyImmunology
2012English

The Effects of an Anti-Cd4 Monoclonal Antibody, Keliximab, on Peripheral Blood CD4+ T-Cells in Asthma

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2001English

Secretory Phospholipase A2-Iid Is an Effector Molecule of CD4+CD25+regulatory T Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

The Transcription Factor C/Ebp Delta Has Anti-Apoptotic and Anti-Inflammatory Roles in Pancreatic Beta Cells

PLoS ONE
Multidisciplinary
2012English

NCOR1 Orchestrates Transcriptional Landscapes and Effector Functions of CD4+ T Cells

Frontiers in Immunology
AllergyImmunology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy